Mirvetuximab soravtansine
About
Therapy type: Chemotherapy
Therapy strategy: Folate receptor-alpha inhibition
Mappings
NCI Thesaurus: Mirvetuximab Soravtansine (coding:ncit:C102566)
RxNorm: mirvetuximab soravtansine (coding:rxcui:2621548, coding:omop:741947)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | FOLR1 positive | Ovarian Epithelial Tumor | Mirvetuximab soravtansine | |
| FDA (1) | FOLR1 positive | High-Grade Serous Fallopian Tube Cancer | Mirvetuximab soravtansine | |
| FDA (1) | FOLR1 positive | Peritoneal Serous Carcinoma | Mirvetuximab soravtansine |